JP2021530560A5 - - Google Patents
Info
- Publication number
- JP2021530560A5 JP2021530560A5 JP2021521945A JP2021521945A JP2021530560A5 JP 2021530560 A5 JP2021530560 A5 JP 2021530560A5 JP 2021521945 A JP2021521945 A JP 2021521945A JP 2021521945 A JP2021521945 A JP 2021521945A JP 2021530560 A5 JP2021530560 A5 JP 2021530560A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- group
- compound according
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862694918P | 2018-07-06 | 2018-07-06 | |
| US62/694,918 | 2018-07-06 | ||
| US201962827573P | 2019-04-01 | 2019-04-01 | |
| US62/827,573 | 2019-04-01 | ||
| PCT/US2019/040690 WO2020010309A1 (en) | 2018-07-06 | 2019-07-05 | Triazole glycolate oxidase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021530560A JP2021530560A (ja) | 2021-11-11 |
| JP2021530560A5 true JP2021530560A5 (cg-RX-API-DMAC7.html) | 2022-07-13 |
| JP7348705B2 JP7348705B2 (ja) | 2023-09-21 |
Family
ID=67441692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021521945A Active JP7348705B2 (ja) | 2018-07-06 | 2019-07-05 | トリアゾールグリコール酸オキシダーゼ阻害剤 |
Country Status (14)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL279952B2 (en) | 2018-07-06 | 2024-11-01 | Cantero Therapeutics Inc | Triazole glycolate oxidase inhibitors |
| WO2021086874A1 (en) | 2019-11-01 | 2021-05-06 | GyanRx Sciences, Inc. | Heterocyclic carboxylate compounds as glycolate oxidase inhibitors |
| WO2021142155A1 (en) * | 2020-01-08 | 2021-07-15 | Orfan Biotech Inc. | Processes for preparing triazole glycolate oxidase inhibitors |
| WO2022066933A1 (en) * | 2020-09-24 | 2022-03-31 | Chinook Therapeutics Canada, Inc. | Pentafluoro-sulfanyl -substituted triazolyl compounds and methods of use thereof |
| TW202339727A (zh) * | 2021-10-11 | 2023-10-16 | 美商坎特羅治療股份有限公司 | 使用1h-1,2,3-三唑-4-羧酸之治療方法 |
| WO2024109917A1 (zh) * | 2022-11-25 | 2024-05-30 | 西藏海思科制药有限公司 | 一种三唑衍生物及其在医药上的应用 |
| WO2024212137A1 (en) * | 2023-04-12 | 2024-10-17 | Cantero Therapeutics, Inc. | Crystalline forms of a 1h-1, 2, 3-triazole-4-carboxylic acid compound |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0774218B2 (ja) * | 1987-03-02 | 1995-08-09 | 第一製薬株式会社 | ベンゾピラノトリアゾ−ル誘導体 |
| US6187326B1 (en) | 1998-12-29 | 2001-02-13 | Thomas T. Yamashita | Soil amendment composition |
| US7022702B2 (en) | 2000-04-07 | 2006-04-04 | Qlt Inc. | Antiproliferative 1,2,3-thiadiazole compounds |
| KR101190912B1 (ko) | 2003-11-19 | 2012-10-12 | 어레이 바이오파마 인크. | Mek의 헤테로시클릭 억제제 및 그의 사용 방법 |
| EP2316458A1 (en) | 2004-09-20 | 2011-05-04 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
| CN101307307A (zh) * | 2008-07-11 | 2008-11-19 | 华东理工大学 | 一种乙醇酸氧化酶制剂、制备方法及应用 |
| KR20140108594A (ko) | 2012-01-10 | 2014-09-11 | 에프. 호프만-라 로슈 아게 | 피리다진 아미드 화합물 및 syk 저해제로서의 이의 용도 |
| JP5455279B1 (ja) | 2012-10-25 | 2014-03-26 | アサヒグループホールディングス株式会社 | ラテックスの増産方法 |
| TW201437200A (zh) | 2013-01-15 | 2014-10-01 | Intermune Inc | 溶血磷脂酸受體拮抗劑 |
| US9392796B2 (en) | 2013-03-15 | 2016-07-19 | Spogen Biotech Inc. | Plant growth-promoting bacteria and methods of use |
| FR3021843B1 (fr) | 2014-06-06 | 2016-07-08 | Lesaffre & Cie | Methode et composition pour ameliorer la productivite de plantes non legumineuses |
| JP5866035B1 (ja) | 2015-01-08 | 2016-02-17 | アサヒグループホールディングス株式会社 | 有効分げつ促進方法 |
| US10766829B2 (en) | 2015-03-19 | 2020-09-08 | KOHJIN Life Sciences Co., Ltd. | Yeast extract having effect of promoting growth of plant and elongation of root and effect of improving added values of plant |
| EP3386949A4 (en) * | 2015-12-07 | 2019-11-20 | Wake Forest University Health Sciences | GLYCOLATE OXIDASE INHIBITORS AND METHOD FOR USE FOR THE TREATMENT OF NIERSTEIN |
| BR112020013073A2 (pt) * | 2017-12-29 | 2020-12-01 | Biomarin Pharmaceutical Inc. | composto, composto, estereoisômero único ou mistura de estereoisômeros ou sal farmaceuticamente aceitável, composição farmacêutica, método de tratamento de uma doença ou distúrbio e composto ou sal farmaceuticamente aceitável do mesmo |
| WO2019133813A1 (en) | 2017-12-29 | 2019-07-04 | Orfan Biotech Inc. | Glycolate oxidase inhibitors and use thereof |
| WO2019165159A1 (en) | 2018-02-23 | 2019-08-29 | Oxalurx, Inc. | Compounds and methods for treating oxalate-related diseases |
| IL279952B2 (en) | 2018-07-06 | 2024-11-01 | Cantero Therapeutics Inc | Triazole glycolate oxidase inhibitors |
| EP3986863A4 (en) | 2019-06-19 | 2023-01-18 | BioMarin Pharmaceutical Inc. | GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASES |
-
2019
- 2019-07-05 IL IL279952A patent/IL279952B2/en unknown
- 2019-07-05 BR BR112021000050-0A patent/BR112021000050A2/pt unknown
- 2019-07-05 US US17/255,600 patent/US11401246B2/en active Active
- 2019-07-05 KR KR1020217003486A patent/KR102865323B1/ko active Active
- 2019-07-05 EP EP19745452.3A patent/EP3817816A1/en active Pending
- 2019-07-05 SG SG11202012930RA patent/SG11202012930RA/en unknown
- 2019-07-05 AU AU2019297523A patent/AU2019297523B2/en active Active
- 2019-07-05 WO PCT/US2019/040690 patent/WO2020010309A1/en not_active Ceased
- 2019-07-05 PE PE2021000011A patent/PE20210859A1/es unknown
- 2019-07-05 CN CN201980045610.4A patent/CN112399873B/zh active Active
- 2019-07-05 JP JP2021521945A patent/JP7348705B2/ja active Active
- 2019-07-05 MX MX2021000051A patent/MX2021000051A/es unknown
-
2021
- 2021-01-03 SA SA521420951A patent/SA521420951B1/ar unknown
- 2021-02-05 CO CONC2021/0001277A patent/CO2021001277A2/es unknown
-
2022
- 2022-06-17 US US17/843,455 patent/US20230143491A1/en not_active Abandoned